Drug Shortage Report for VYVANSE

Last updated on 2018-06-13 History
Report ID 51253
Drug Identification Number 02458071
Brand name VYVANSE
Common or Proper name Lisdexamfetamine Dimesylate capsules
Company Name SHIRE PHARMA CANADA ULC
Active Ingredient(s) LISDEXAMFETAMINE DIMESYLATE
Strength(s) 70MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100's
ATC code N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Demand increase for the drug.
Anticipated start date 2018-06-06
Actual start date
Estimated end date 2018-06-13
Actual end date 2018-06-12
Shortage status Resolved
Updated date 2018-06-13
Company comments Shire do not anticipate shortage at the pharmacist level.
Health Canada comments
Contact Address 22 ADELAIDE ST WEST, SUITE 3800
TORONTO, ONTARIO
CANADA M5H 4E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2018-06-13 English Compare
v9 2018-06-12 French Compare
v8 2018-06-12 English Compare
v7 2018-06-07 English Compare
v6 2018-06-04 French Compare
v5 2018-06-04 English Compare
v4 2018-06-04 French Compare
v3 2018-06-04 English Compare
v2 2018-06-04 French Compare
v1 2018-06-04 English Compare